Clinical Trial Update: Psilocybin for Treatment of Obsessive Compulsive Disorder [Phase 1]

View source ↗

Summary

A completed Phase 1 trial evaluated the safety and tolerability of psilocybin for obsessive-compulsive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: University of Arizona | Conditions: Obsessive-compulsive Disorder (OCD) | Phase 1 | Status: COMPLETED